Fluoride

Fluoride

SCHEMBL25237517

C=CCOc1ccc(OS(=O)(=O)O)cc1.F

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.57
▸ CA1 P00915 3/20 0.57
▸ CA9 Q16790 3/20 0.57
▸ CA2 P00918 1/20 0.57
▸ CA7 P43166 1/20 0.57
▸ NPC1 O15118 4/20 0.42
▸ MAPT P10636 4/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ POLB P06746 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ ADRA2A P08913 1/20 0.41
▸ ADRA2B P18089 1/20 0.41
▸ ADRA2C P18825 1/20 0.41
▸ SLC5A1 P13866 1/20 0.40
▸ SLC5A2 P31639 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25672270 0.80 CA12 (0.59) CA12CA1CA9CA2CA7
SCHEMBL4813146 0.80 CA12 (0.69) CA12CA1CA9CA2CA7
SCHEMBL3725958 0.79 CA12 (0.67) CA12CA1CA9CA2CA7
1,4-Diallyloxybenzene SCHEMBL302448 0.78 CA12 (0.63) CA12CA1CA9CA2CA7
Sulfuric Acid SCHEMBL432916 0.78 CA12 (0.56) CA12CA1CA9CA2CA7
SCHEMBL31256546 0.77 CA12 (0.56) CA12CA1CA9CA2CA7
SCHEMBL25283799 0.77 CA12 (0.56) CA12CA1CA9CA2CA7
Sulfuric Acid SCHEMBL1074746 0.76 CA12 (0.54) CA12CA1CA9CA2CA7
Sulfuric Acid SCHEMBL9350034 0.76 CA12 (0.54) CA12CA1CA9CA2CA7
Sulfuric Acid SCHEMBL27551874 0.76 CA12 (0.54) CA12CA1CA9CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12322756-B2 Electrolyte solution for lithium secondary battery and lithium secondary battery including same HYUNDAI MOTOR COMPANY (KR) 2025-06-03 — — US claimed
US-20230207875-A1 ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME KIA MOTORS CORPORATION (KR) 2023-06-29 — — US claimed
US-12322756-B2 Electrolyte solution for lithium secondary battery and lithium secondary battery including same HYUNDAI MOTOR COMPANY (KR) 2025-06-03 — — US disclosed
CN-116417664-A Electrolyte solution for lithium secondary battery and lithium secondary battery comprising the same 现代自动车株式会社 2023-07-11 — — CN disclosed
US-20230207875-A1 ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME KIA MOTORS CORPORATION (KR) 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230207875-A1 ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING SAME LDHB, SOD1, CACNA1F CA12 325/4885CA1 291/4885CA9 192/4885
US-12322756-B2 Electrolyte solution for lithium secondary battery and lithium secondary battery including same LDHB, SOD1, CACNA1F CA12 325/4885CA1 291/4885CA9 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback